Louis Bont focuses on Immunology, Pediatrics, Bronchiolitis, Virus and Respiratory system. His Immunology research is multidisciplinary, incorporating perspectives in Respiratory tract and Disease. His Pediatrics research incorporates themes from Palivizumab, Gestational age, Incidence, Respiratory sounds and Lower respiratory tract infection.
His Bronchiolitis study which covers Cellular immunity that intersects with Respiratory disease, Pneumovirinae, Mononegavirales and Paramyxoviridae. His Virus study combines topics in areas such as El Niño, Clinical trial and Child mortality. His studies deal with areas such as Vitamin D and neurology and Epidemiology as well as Respiratory system.
His scientific interests lie mostly in Immunology, Bronchiolitis, Pediatrics, Respiratory system and Virus. Immunology and Respiratory disease are frequently intertwined in his study. His Bronchiolitis study deals with Epidemiology intersecting with Incidence.
The various areas that Louis Bont examines in his Pediatrics study include Palivizumab, Respiratory tract infections, Lower respiratory tract infection, Gestational age and Prospective cohort study. His work in Respiratory system tackles topics such as Mechanical ventilation which are related to areas like Breathing. His studies in Virus integrate themes in fields like Clinical trial, Disease and Immunopathology.
His primary scientific interests are in Virus, Virology, Immunology, Respiratory system and Pediatrics. His study in the fields of Emergent virus and Rotavirus under the domain of Virus overlaps with other disciplines such as Heterologous vaccine and Salmonella typhi. His Virology research integrates issues from Monoclonal antibody, Respiratory Syncytial Virus Vaccines, Molecular epidemiology and MEDLINE.
His study in Palivizumab, Bronchiolitis, Wheeze, Immunopathology and Inflammation is carried out as part of his studies in Immunology. His biological study spans a wide range of topics, including Transcriptome, Clinical trial and Immune system. He has researched Pediatrics in several fields, including Incidence, Cohort study, Increased risk, Confidence interval and Prospective cohort study.
Immunology, Bronchiolitis, Pediatrics, Disease and Virus are his primary areas of study. Louis Bont interconnects Receptor and In vitro in the investigation of issues within Immunology. The study incorporates disciplines such as Genetic diversity, Genetic variation, Metabolomic profiling, Metabolomics and Urine in addition to Bronchiolitis.
His Pediatrics research includes themes of Surveillance data, Age distribution, Respiratory syncytial virus and Confidence interval. His Disease research incorporates elements of Public health, Lower respiratory tract infection and Immunopathology. Louis Bont has included themes like Peripheral blood mononuclear cell, Antibody, Monoclonal antibody and In vivo in his Virus study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study
Ting Shi;David A. McAllister;Katherine L. O'Brien;Eric A. F. Simoes.
The Lancet (2017)
Respiratory syncytial virus and recurrent wheeze in healthy preterm infants.
Maarten O Blanken;Maroeska M Rovers;Jorine M Molenaar;Pauline L Winkler-Seinstra.
The New England Journal of Medicine (2013)
Cord Blood Vitamin D Deficiency is Associated With Respiratory Syncytial Virus Bronchiolitis
Mirjam E. Belderbos;Michiel L. Houben;Berry Wilbrink;Eef Lentjes.
Long-term expanding human airway organoids for disease modeling
Norman Sachs;Angelos Papaspyropoulos;Domenique D. Zomer-van Ommen;Inha Heo.
The EMBO Journal (2019)
Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes
Riny Janssen;Louis Bont;Christine L. E. Siezen;Hennie M. Hodemaekers.
The Journal of Infectious Diseases (2007)
Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review.
N G Papadopoulos;I Christodoulou;G Rohde;I Agache.
The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates.
Natalie I Mazur;Deborah Higgins;Marta C Nunes;José A Melero.
Lancet Infectious Diseases (2018)
Down Syndrome: A Novel Risk Factor for Respiratory Syncytial Virus Bronchiolitis— A Prospective Birth-Cohort Study
Beatrijs L P Bloemers;A. Marceline Van Furth;Michel E. Weijerman;Reinoud J B J Gemke.
Association of Severe Respiratory Syncytial Virus Bronchiolitis with Interleukin-4 and Interleukin-4 Receptor α Polymorphisms
Barbara Hoebee;Edwin Rietveld;Louis Bont;Marijke van Oosten.
The Journal of Infectious Diseases (2003)
Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics
Natalie I Mazur;Federico Martinón-Torres;Eugenio Baraldi;Brigitte Fauroux.
The Lancet Respiratory Medicine (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: